Arlehamn; Cecilia Lindestam
Patent Applications and Registrations
Patent applications and USPTO patent grants for Arlehamn; Cecilia Lindestam.The latest application filed is for "use of peptides as biomarkers in the diagnosis, confirmation and treatment of a neurological disorder and tcr and/or hla immunop".
- Arlehamn; Cecilia Lindestam - La Jolla CA
| Patent | Date |
|---|---|
| Use Of Peptides As Biomarkers In The Diagnosis, Confirmation And Treatment Of A Neurological Disorder And Tcr And/or Hla Immunop App 20200095296 - Sulzer; David ; et al. | 2020-03-26 |
| Specific and unique T cell responses and molecular signatures for the treatment and diagnosis of Mycobacterium tuberculosis Grant 10,406,218 - Sette , et al. Sept | 2019-09-10 |
| Specific And Unique T Cell Responses And Molecular Signatures For The Treatment And Diagnosis Of Mycobacterium Tuberculosis App 20170028049 - Sette; Alessandro ; et al. | 2017-02-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 